Your ElderTech deal isn't determined by a single buyer – it's decided by a clinical lead, an IT/security reviewer, a procurement officer, and an executive sponsor, all evaluating different materials against different standards. Winston Francois creates the stakeholder-specific evidence, documentation, and objection-handling library needed to move a deal through every seat at the table, not only the first one.
The Challenge
A single deck can't satisfy a four-person buying committee
A PACE program or Medicare Advantage plan doesn't buy the way a single-decision-maker SMB does. Clinical, IT/security, procurement, and an executive sponsor each judge your product by a different standard, and most ElderTech sales teams hand all four the same generic pitch deck. Neither the clinical nor the security reviewer gets what they need, so the deal stalls waiting for materials that don't exist yet.
Clinical stakeholders are skeptical of marketing language
A clinical lead wants to know how your outcomes were measured and how they compare to standard of care, not adjectives. Reps without evidence packaging built for that audience either oversell in a way that gets challenged in the room, or undersell because they're afraid to make a claim they can't back up. Both cost you credibility with the one stakeholder who can veto the deal.
Momentum dies in security review when documentation isn't prepared
Institutional buyers won't move past IT/security review without a HIPAA business associate agreement, current SOC 2 status, and a clear data handling explanation – and most ElderTech teams are building these from scratch, mid-deal, under pressure. That delay reads as disorganization and hands a security-savvy competitor an opening.
With long cycles, most deals die in the stall rather than the pitch
A 6 to 18 month sales cycle has multiple points where a deal can quietly go cold: a procurement delay, a security pushback, a champion who can't build internal consensus without a business case to hand up to their own leadership. Reps trained only on the opening pitch have nothing to say when the deal stalls at month nine.
How We Support You
We begin with an audit, not a workshop. We join live or recorded sales calls, review your last dozen closed-lost deals, and pinpoint exactly where each one stalled – clinical pushback, security review, procurement delay, or a champion who went silent without anything to escalate internally. Most ElderTech teams think they need a stronger pitch deck; the audit typically reveals that the true gap appears three stages after the pitch.
We then create a stakeholder-specific materials library rather than a single master deck: a clinical evidence packet that expresses outcomes in language a clinical reviewer can trust without overclaiming, a security and compliance documentation set designed to pass IT review on the first attempt, and a procurement-focused ROI case that a champion can defend to their own leadership.
Competitive positioning receives the same level of specificity. We create battlecards for named ElderTech competitors, as well as for the alternative that appears in more deals than any one competitor: doing nothing, whether that means a legacy medical alert vendor, a manual care-coordination process, or a generic care management platform that wasn't designed for aging populations.
We prepare for the stall as well, because that's where most ElderTech sales cycles actually end: objection-handling scripts for procurement delays, a playbook for security reviews stretching into month three, and consensus-building materials that a champion can share internally when no rep is in the room.
Unlike a traditional agency, we're fractional and embedded. We participate in your sales meetings and make revisions based on what truly happens in the room, rather than waiting for a quarterly review cycle. You work with operators who have created enablement materials before, alongside the growth strategy and marketing positioning we deliver for the same account, with the measurement discipline used across every Winston Francois engagement. If your reps keep losing deals at a particular stage, book a strategy call and we'll explain the audit approach before you commit to anything.
What we deliver
- Stakeholder-specific pitch deck library (clinical, IT/security, procurement, executive)
- Clinical evidence packet translating outcomes into methodology and standard-of-care comparison
- HIPAA business associate agreement template, SOC 2 status sheet, and data handling FAQ
- Competitive battlecards covering named competitors and the do-nothing / legacy alternative
- ROI and cost-avoidance business case template for procurement and executive sponsors
- Objection-handling playbook for procurement delays and security review pushback
- Rep onboarding and live-call coaching on the new materials
Your ElderTech deal isn't lost during the pitch – it's lost in month nine when your champion has nothing to give their own boss.
Our Methodology
We deliver this through a 90-day sprint rather than an indefinite retainer. The first 30 days focus on audit: we examine closed-lost deals, join live calls, and interview your reps along with your clinical or product lead to identify which materials are absent and which existing assets go unused. This phase concludes with a prioritized gap list, not a generic deck of recommendations.
Days 31 to 60 focus on building. We create stakeholder-specific materials in order of priority – generally starting with security and compliance documentation because it's the most frequent hard stop, then moving to clinical evidence packaging and the ROI case. Your product and clinical teams participate throughout the build instead of reviewing everything afterward, because that handoff is often where oversold or unsupported claims enter the materials.
Days 61 to 90 cover deployment and measurement. We train your reps live on the new materials, then revise them based on what resonates and what causes conversations to stall. By day 90, you'll have a functional library rather than a collateral folder that nobody opens.
Our Working Approach
The engagement follows the methodology's same 30/60/90 framework, but its effectiveness comes from the team structure. You work with a fractional lead who has previously developed enablement for regulated, multi-stakeholder sales motions, partnering directly with your VP of Sales or Marketing and the person responsible for clinical and compliance content on your team. No account manager stands between you and the person completing the work.
During the build phase, we meet weekly – using real deal feedback to evaluate drafts rather than simply giving status updates. In deployment, we join a rotating selection of live sales calls, allowing us to test materials against genuine clinical and procurement objections instead of relying on our assumptions.
Following day 90, most clients shift to a lighter monthly schedule that keeps the library updated as competitors evolve or your product releases new outcomes data. The first usable deliverable, usually the security and compliance documentation set, should arrive within three to four weeks because it's the asset most often holding up active deals.
- Fewer deals stalled waiting on HIPAA BAA or SOC 2 documentation during security review
- Clinical stakeholders engaging further into the deal instead of exiting after the first call
- Champions able to escalate internally with a defensible ROI or cost-avoidance case
- More consistent messaging across clinical, IT, procurement, and executive stakeholders
- Faster ramp time for new reps navigating multi-stakeholder institutional sales
If your eldertech / agetech company needs sales enablement leadership, we should talk.
Expand your marketing team output with our experts
Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.
Frequently asked questions
What does ElderTech sales enablement from Winston Francois cost?
Pricing is based on the 90-day sprint and adjusts according to how much of your materials library is already in place. Most ElderTech engagements fall within the mid five-figure range for the complete sprint, followed by a lighter monthly retainer. After the audit call, you receive a fixed sprint price rather than an open-ended hourly estimate.
When can we expect to see results?
Your reps receive the highest-priority deliverable, typically the security and compliance documentation, within three to four weeks. The complete library is generally deployed by day 90. Since ElderTech sales cycles take 6 to 18 months, you should expect fewer deals to stall over the next quarter or two, rather than an instant increase in close rates.
Who completes the work, and how much time will my team need to contribute?
The engagement is led directly by a fractional lead with institutional healthcare sales experience, who works weekly with your VP of Sales or Marketing and the person responsible for clinical or compliance content. Your team's involvement is greatest during the audit phase, then decreases throughout build and deployment.
What makes this different from a general sales enablement agency or a marketing agency that creates decks?
Most agencies produce one refined pitch deck and label it enablement. We create materials for the buying committee that actually shapes ElderTech deals – clinical, security, procurement, executive – and address the stall as well as the pitch. As a fractional, embedded partner, we join your real sales calls.
How do you determine whether the enablement materials are really working?
We monitor which materials are used in active deals and which remain unopened, while joining a rotating selection of calls throughout deployment. When an asset doesn't help stalled deals progress, we remove or rebuild it. It's the same measurement discipline we bring to the broader measurement work delivered for growth clients.
Which type of ElderTech company is the strongest fit for this engagement?
This engagement is best suited to Series A through growth-stage ElderTech companies selling to health systems, PACE programs, senior living operators, or Medicare Advantage plans, where a multi-stakeholder buying committee is involved in each deal. If your primary customers are individual consumers with one decision-maker, a lighter marketing engagement offers a better place to begin.
